Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Kunlun Capital

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 13
Average round size
info
The average size of a deal this fund participated in
$131M
Portfolio companies 11
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.15
Key employees Soon
Stages of investment
Late Stage Venture
Private Equity

Areas of investment

  • Biotechnology
  • Medical
  • Genetics
  • Artificial Intelligence
  • Health Care

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Kunlun Capital:
Typical Co-investors
Kunlun Capital is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Kunlun Capital:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from Singapore
Funds with similar focus located in Singapore:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
British Airways England, London, United Kingdom
Congruent Ventures California, Oakland, United States
Consort Medical Hemel Hempstead, Hertfordshire, United Kingdom
Fifth Province Ventures County Dublin, Dublin, Ireland
Fujian Ocean Group -
Ganexa Capital Lisboa, Lisbon, Portugal
Interactive Project LLC -
JITO Incubation and Innovation Foundation (JIIF) -
Korea Information Certificate Authority (KICA) -
Krohne -
Neglected Climate Opportunities -
New England Partners Massachusetts, Quincy, United States
Potential Invest -
TNN Capital Luxembourg, Luxembourg
Trinvest AB -
Wilmington Investor Network North Carolina, United States, Wilmington
Zhejiang Zheshang Industry-finance Equity Investment Fund -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Hui-Gene Therapeutics

Biotechnology
Genetics
Life Science
Therapeutics
12 May 2022 Shanghai, China

UniXell

Biotechnology
Medical
$30M14 Mar 2022 Shanghai, Shanghai, China

Zhongke Digital

Artificial Intelligence
Blockchain
Computer
Finance
21 Dec 2021 Haidian District, Beijing, China

Circular Code Biology

Biopharma
Biotechnology
Genetics
Pharmaceutical
$20M16 Dec 2021 Shanghai, Shanghai, China

Danwang Medical

Biopharma
Biotechnology
Medical
Product Research
$18M14 Oct 2021 Shanghai, Shanghai, China

UniXell

Biotechnology
Medical
01 Aug 2021 Shanghai, Shanghai, China

EdiGene

Biotechnology
Genetics
Health Care
$61M21 Apr 2021 Dongcheng District, Beijing, China

Biotheus

Biotechnology
Health Care
03 Mar 2021 Xiangzhou District, Guangdong Province, China

NeoCura

Artificial Intelligence
Biotechnology
Software
$38M23 Dec 2020 Beijing, Beijing, China

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Kunlun Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 13
Average round size 131M
Peak activity year 2021
Lead investments 0
Follow on index 0.15
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Hui-Gene Therapeutics

Biotechnology
Genetics
Life Science
Therapeutics
12 May 2022 Shanghai, China

UniXell

Biotechnology
Medical
$30M14 Mar 2022 Shanghai, Shanghai, China

Zhongke Digital

Artificial Intelligence
Blockchain
Computer
Finance
21 Dec 2021 Haidian District, Beijing, China

Circular Code Biology

Biopharma
Biotechnology
Genetics
Pharmaceutical
$20M16 Dec 2021 Shanghai, Shanghai, China

Danwang Medical

Biopharma
Biotechnology
Medical
Product Research
$18M14 Oct 2021 Shanghai, Shanghai, China

UniXell

Biotechnology
Medical
01 Aug 2021 Shanghai, Shanghai, China

EdiGene

Biotechnology
Genetics
Health Care
$61M21 Apr 2021 Dongcheng District, Beijing, China

Biotheus

Biotechnology
Health Care
03 Mar 2021 Xiangzhou District, Guangdong Province, China

NeoCura

Artificial Intelligence
Biotechnology
Software
$38M23 Dec 2020 Beijing, Beijing, China
Crunchbase icon

Content report

The following text will be sent to our editors: